Current and emerging strategies for management of myelodysplastic syndromes.
Sign Up to like & getrecommendations! Published in 2020 at "Blood reviews"
DOI: 10.1016/j.blre.2020.100791
Abstract: Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis with varying degrees of dysplasia and peripheral cytopenias. MDS are driven by structural chromosomal alterations and somatic mutations in neoplastic myeloid cells, which are supported by a… read more here.
Keywords: strategies management; myelodysplastic syndromes; management myelodysplastic; emerging strategies ... See more keywords